MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock, atm...
$16,359K
Proceeds from the
exercise of stock options
$350K
Issuance of common stock
under espp
$217K
Net cash provided by
financing activities
$16,226K
Canceled cashflow
$700K
Net change in cash
$3,785K
Canceled cashflow
$12,441K
Payment of license
installment note payable
$625K
Payment of debt issuance
costs
$75K
Accrued expenses
$10,149K
Share-based compensation
$6,288K
Inventory
-$4,807K
Amortization of acquired
intangible assets
$4,258K
Amortization of debt discount
$466K
Amortization of operating
lease right-of-use...
$88K
Income tax payable
$10K
Net cash (used in)
operating activities
-$12,441K
Canceled cashflow
$26,066K
Accounts receivable
$19,341K
Net loss
-$11,431K
Accounts payable
-$7,199K
Bad debt (recovery)
expense
-$211K
Prepaid expenses and
other current assets
$164K
Lease liabilities
-$82K
Related party expenses
-$73K
Accrued interest
-$6K
Back
Back
Cash Flow
source: myfinsight.com
Journey Medical Corp (DERM)
Journey Medical Corp (DERM)